Safety of uninterrupted periprocedural edoxaban vs phenprocoumon for patients undergoing left atrial catheter ablation procedures
The American Journal of Cardiology Nov 30, 2017
Kottmaier M, et al. - In this study, the safety of uninterrupted edoxaban was compared with that of uninterrupted phenprocoumon when administered during left atrial (LA) radiofrequency (RF) ablation for atrial fibrillation (AF) and atrial tachycardia (AT). In patients undergoing LA RF ablation procedures, uninterrupted oral anticoagulation (OAC) with edoxaban or with phenprocoumon appeared equally safe.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries